Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 12, 2016 - Issue 1
Submit an article Journal homepage
1,056
Views
42
CrossRef citations to date
0
Altmetric
Reviews

New toxicity profile for novel immunotherapy agents: focus on immune-checkpoint inhibitors

C CiccareseMedical Oncology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona37124, Italy
,
S AlfieriSSD Oncologia medica Tumori Testa e Collo, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milano20133, Italy
,
M SantoniClinica di Oncologia Medica, AOU “Ospedali Riuniti”, Polytechnic University of the Marche Region, Ancona60126, Italy
,
D SantiniDepartment of Medical Oncology, Campus Bio-Medico University, Oncologia Medica, Rome, Italy
,
M BrunelliDepartment of Pathology and Diagnostic, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona37124, Italy
,
C BergaminiSSD Oncologia medica Tumori Testa e Collo, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milano20133, Italy
,
L LicitraSSD Oncologia medica Tumori Testa e Collo, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milano20133, Italy
,
R MontironiSection of Pathological Anatomy, School of Medicine, AOU Ospedali Riuniti, Polytechnic University of the Marche Region, Ancona60126, Italy
,
G TortoraMedical Oncology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona37124, Italy
&
F MassariMedical Oncology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona37124, ItalyCorrespondence[email protected]
 show all
Pages 57-75 | Published online: 08 Dec 2015

Citations (42)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Anna M Czarnecka & Piotr Rutkowski. (2020) An update on the safety of nivolumab for the treatment of advanced melanoma. Expert Opinion on Drug Safety 19:4, pages 409-421.
Read now
Debora Basile, Silvio Ken Garattini, Marta Bonotto, Elena Ongaro, Mariaelena Casagrande, Monica Cattaneo, Valentina Fanotto, Elisa De Carlo, Fotios Loupakis, Federica Urbano, Francesca V. Negri, Nicoletta Pella, Marco Russano, Oronzo Brunetti, Mario Scartozzi, Daniele Santini, Nicola Silvestris, Andrea Casadei Gardini, Marco Puzzoni, Lorenzo Calvetti, Nadia Cardarelli & Giuseppe Aprile. (2017) Immunotherapy for colorectal cancer: where are we heading?. Expert Opinion on Biological Therapy 17:6, pages 709-721.
Read now
Tomohide Tsukahara, Makoto Emori, Kenji Murata, Emi Mizushima, Yuji Shibayama, Terufumi Kubo, Takayuki Kanaseki, Yoshihiko Hirohashi, Toshihiko Yamashita, Noriyuki Sato & Toshihiko Torigoe. (2016) The future of immunotherapy for sarcoma. Expert Opinion on Biological Therapy 16:8, pages 1049-1057.
Read now

Articles from other publishers (39)

Haojie Shang, Jian Wu, Xiao Liu, Yonghua Tong, Yu He, Qiu Huang, Ding Xia, Ejun Peng, Zhiqiang Chen & Kun Tang. (2023) Second near-infrared nanomaterials for cancer photothermal immunotherapy. Materials Today Advances 17, pages 100339.
Crossref
Matteo Santoni, Javier Molina-Cerrillo, Giorgio Santoni, Elaine T. Lam, Francesco Massari, Veronica Mollica, Giulia Mazzaschi, Bernardo L. Rapoport, Enrique Grande & Sebastiano Buti. (2023) Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic Consequences. Cancers 15:2, pages 408.
Crossref
Cihan Erol & Mehmet Ali Nahit Sendur. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 13 .
Thomas K. Le, Isabelle Brown, Rebecca Goldberg, Matthew T. Taylor, Junwen Deng, Varsha Parthasarathy, Zachary A. Bordeaux, Martin Prince Alphonse, Madan M. Kwatra, Vivek Naranbhai, Alexander Gusev, Jihad Alhariri, Nicole R. LeBoeuf, Kerry L. Reynolds, Laura C. Cappelli, Jarushka Naidoo, Julie R. Brahmer, Sewon Kang, Yevgeniy R. Semenov & Shawn G. Kwatra. (2022) Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Pharmacovigilance Study. Journal of Investigative Dermatology 142:11, pages 2896-2908.e4.
Crossref
Gianluca Nazzaro, Stefano Buffon, Serena Giacalone, Carlo Alberto Maronese & Angelo Valerio Marzano. (2022) Skin manifestations associated with checkpoint inhibitors. JEADV Clinical Practice 1:2, pages 73-87.
Crossref
Wei Yang, Xiaofeng Xu, Dajing Xia, Huaichong Wang, Jing Jiang & Guoliang Yang. (2022) Toxic epidermal necrolysis associated with chemoimmunotherapy for lymphoma: case report and literature review. Immunotherapy 14:5, pages 275-282.
Crossref
Lorena Villa-Crespo, Sebastian Podlipnik, Natalia Anglada, Clara Izquierdo, Priscila Giavedoni, Pablo Iglesias, Mireia Dominguez, Francisco Aya, Ana Arance, Josep Malvehy, Susana Puig & Cristina Carrera. (2022) Timeline of Adverse Events during Immune Checkpoint Inhibitors for Advanced Melanoma and Their Impacts on Survival. Cancers 14:5, pages 1237.
Crossref
Yanhong Zhang, Changli Yue, Anna M. Krichevsky & Igor Garkavtsev. (2022) Repression of the stress granule protein G3BP2 inhibits immune checkpoint molecule PD‐L1. Molecular Oncology.
Crossref
Xiang Li, Li-Xin Qu, Yu-Mei Ren & Chang Hu. (2021) Case Report: A Case Report and Literature Review on Severe Bullous Skin Reaction Induced by anti-PD-1 Immunotherapy in a Cervical Cancer Patient. Frontiers in Pharmacology 12.
Crossref
Silpita Paul & Gaurisankar Sa. (2021) Curcumin as an Adjuvant to Cancer Immunotherapy. Frontiers in Oncology 11.
Crossref
Xin Shou, Yuxiao Liu, Dan Wu, Hui Zhang, Yuanjin Zhao, Weijian Sun & Xian Shen. (2021) Black phosphorus quantum dots doped multifunctional hydrogel particles for cancer immunotherapy. Chemical Engineering Journal 408, pages 127349.
Crossref
Sabina Y. van der Zanden, Jolien J. Luimstra, Jacques Neefjes, Jannie Borst & Huib Ovaa. (2020) Opportunities for Small Molecules in Cancer Immunotherapy. Trends in Immunology 41:6, pages 493-511.
Crossref
Avishek Bhuniya, Ipsita Guha, Nilanjan Ganguly, Akata Saha, Shayani Dasgupta, Partha Nandi, Arnab Das, Sarbari Ghosh, Tithi Ghosh, Enamul Haque, Saptak Banerjee, Anamika Bose & Rathindranath Baral. (2020) NLGP Attenuates Murine Melanoma and Carcinoma Metastasis by Modulating Cytotoxic CD8+ T Cells. Frontiers in Oncology 10.
Crossref
Shakuntala H. Mauzo, Michael T. Tetzlaff, Kelly Nelson, Rodabe Amaria, Sapna Patel, Phyu P. Aung, Priyadharsini Nagarajan, Carlos A. Torres‐Cabala, Adi Diab, Victor G. Prieto & Jonathan L. Curry. (2017) Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade. International Journal of Dermatology 58:9, pages 1045-1052.
Crossref
Rana Shafabakhsh, Mohammad Hossein Pourhanifeh, Hamid Reza Mirzaei, Amirhossein Sahebkar, Zatollah Asemi & Hamed Mirzaei. (2019) Targeting regulatory T cells by curcumin: A potential for cancer immunotherapy. Pharmacological Research 147, pages 104353.
Crossref
Elizabeth A. Blakeway, Noha Elshimy, Andrew Muinonen-Martin, Maria Marples, Bipin Mathew & Angana Mitra. (2019) Cutaneous lupus associated with pembrolizumab therapy for advanced melanoma: a report of three cases. Melanoma Research 29:3, pages 338-341.
Crossref
Yajaira Hernandez-SalasPhDPhD, Fernando Hernandez-TeranPhDPhD, Nagamani BalaguramyPhDPhD & Norma De La Fuente-SalcidoPhDPhD. (2019) Alternativa biotecnológica contra el cáncer: Parasporinas de Bacillus thuringiensis. Revista de Ingeniería Biomédica y Biotecnología, pages 8-17.
Crossref
John A. ThompsonBryan J. SchneiderJulie BrahmerStephanie AndrewsPhilippe ArmandShailender BhatiaLihua E. BuddeLuciano CostaMarianne DaviesDavid DunningtonMarc S. ErnstoffMatthew FrigaultBrianna HoffnerChristopher J. HoimesMario LacoutureFrederick LockeMatthew LunningNisha A. MohindraJarushka NaidooAnthony J. OlszanskiOlalekan OluwoleSandip P. PatelSunil ReddyMabel RyderBianca SantomassoScott ShoferJeffrey A. SosmanMomen WahidiYinghong Wang, Alyse Johnson-ChillaJillian L. Scavone. (2019) Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 17:3, pages 255-289.
Crossref
Yong Li, Xiaosong Li, Austin Doughty, Connor West, Lu wang, Feifan Zhou, Robert E. Nordquist & Wei R. Chen. (2019) Phototherapy using immunologically modified carbon nanotubes to potentiate checkpoint blockade for metastatic breast cancer. Nanomedicine: Nanotechnology, Biology and Medicine.
Crossref
Yang Lu. (2019) FDG PET/CT Course of Pembrolizumab-Associated Multiorgan Sarcoidosis. Clinical Nuclear Medicine 44:2, pages 167-168.
Crossref
Wenhong Li, Zhigang Wei, Xia Yang, Guanghui Huang, Xiaoying Han, Yang Ni, Jiao Wang, Min Meng, Zhigeng Zou, Qiang Wen & Xin Ye. (2019) Salvage therapy of reactive capillary hemangiomas: Apatinib alleviates the unique adverse events induced by camrelizumab in non-small cell lung cancer. Journal of Cancer Research and Therapeutics 15:7, pages 1624.
Crossref
Lauren Penn, Lisa Rothman, Angela M. Sutton, Nooshin K. Brinster & Claudia I. Vidal. (2019) What’s New in Dermatopathology: Inflammatory Dermatoses. Advances in Anatomic Pathology 26:1, pages 40-55.
Crossref
Jeffrey Yang & Longqin Hu. (2019) Immunomodulators targeting the PD-1/PD-L1 protein-protein interaction: From antibodies to small molecules. Medicinal Research Reviews 39:1, pages 265-301.
Crossref
Michael T. Tetzlaff, Kelly C. Nelson, Adi Diab, Gregg A. Staerkel, Priyadharsini Nagarajan, Carlos A. Torres-Cabala, Beth A. Chasen, Jennifer A. Wargo, Victor G. Prieto, Rodabe N. Amaria & Jonathan L. Curry. (2018) Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients. Journal for ImmunoTherapy of Cancer 6:1.
Crossref
Antonio Lopez-Beltran, Vanessa Henriques, Alessia Cimadamore, Matteo Santoni, Liang Cheng, Thomas Gevaert, Ana Blanca, Francesco Massari, Marina Scarpelli & Rodolfo Montironi. (2018) The Identification of Immunological Biomarkers in Kidney Cancers. Frontiers in Oncology 8.
Crossref
Celestine Trinidad, Kelly C. Nelson, Isabella C. Glitza Oliva, Carlos A. Torres-Cabala, Priyadharsini Nagarajan, Michael T. Tetzlaff, Doina Ivan, Wen-Jen Hwu, Victor G. Prieto, Jonathan L. Curry & Phyu P. Aung. (2018) Dermatologic toxicity from immune checkpoint blockade therapy with an interstitial granulomatous pattern. Journal of Cutaneous Pathology 45:7, pages 504-507.
Crossref
Anagha Bangalore Kumar, Rachel Maus & Svetomir N. Markovic. (2018) Pharmacologic Modulation of Human Immunity in the Era of Immuno-oncology: Something Old, Something New. Mayo Clinic Proceedings 93:7, pages 917-936.
Crossref
Kimberly Shao, Suzanne McGettigan, Rosalie Elenitsas & Emily Y. Chu. (2018) Lupus-like cutaneous reaction following pembrolizumab: An immune-related adverse event associated with anti-PD-1 therapy. Journal of Cutaneous Pathology 45:1, pages 74-77.
Crossref
Michael T. Tetzlaff, Amir A. Jazaeri, Carlos A. Torres-Cabala, Brinda R. Korivi, Genie A. Landon, Priyadharsini Nagarajan, Adrienne Choksi, Leon Chen, Marc Uemura, Phyu P. Aung, Adi Diab, Padmanee Sharma, Michael A. Davies, Rodabe Amaria, Victor G. Prieto & Jonathan L. Curry. (2017) Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patients. Journal of Cutaneous Pathology 44:12, pages 1080-1086.
Crossref
Simone Negrini & Laurent Becquemont. (2017) HLA-associated drug hypersensitivity and the prediction of adverse drug reactions. Pharmacogenomics 18:15, pages 1441-1457.
Crossref
Chiara Ciccarese, Roberto Iacovelli, Emilio Bria, Alessandra Modena, Francesco Massari, Matteo Brunelli, Emanuela Fantinel, Davide Bimbatti, Giulia A Zamboni, Walter Artibani & Giampaolo Tortora. (2017) The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies. Immunotherapy 9:7, pages 579-587.
Crossref
Jessica C. Hassel, Lucie Heinzerling, Jens Aberle, Oliver Bähr, Thomas K. Eigentler, Marc-Oliver Grimm, Victor Grünwald, Jan Leipe, Niels Reinmuth, Julia K. Tietze, Jörg Trojan, Lisa Zimmer & Ralf Gutzmer. (2017) Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions. Cancer Treatment Reviews 57, pages 36-49.
Crossref
Susanne Unverzagt, Ines Moldenhauer, Monika Nothacker, Dorothea Roßmeißl, Andreas V Hadjinicolaou, Frank Peinemann, Francesco Greco & Barbara Seliger. (2017) Immunotherapy for metastatic renal cell carcinoma. Cochrane Database of Systematic Reviews 2017:5.
Crossref
Roberto IacovelliChiara Ciccarese, Emanuela Fantinel, Davide Bimbatti, Mario Romano, Antonio Benito Porcaro, Salvatore Siracusano, Renzo Mazzarotto, Walter Artibani & Giampaolo Tortora. (2018) Renal Toxicity in Patients Treated with Anti-Pd-1 Targeted Agents for Solid Tumors. Journal of Onco-Nephrology 1:2, pages 132-142.
Crossref
Jonathan L. Curry, Michael T. Tetzlaff, Priyadharsini Nagarajan, Carol Drucker, Adi Diab, Sharon R. Hymes, Madeleine Duvic, Wen-Jen Hwu, Jennifer A. Wargo, Carlos A. Torres-Cabala, Ronald P. Rapini & Victor G. Prieto. (2017) Diverse types of dermatologic toxicities from immune checkpoint blockade therapy. Journal of Cutaneous Pathology 44:2, pages 158-176.
Crossref
Michael R. Yeaman & John P. HennesseyJr.Jr.. (2017) Innovative Approaches to Improve Anti-Infective Vaccine Efficacy. Annual Review of Pharmacology and Toxicology 57:1, pages 189-222.
Crossref
Letizia Procaccio, Marta Schirripa, Matteo Fassan, Loredana Vecchione, Francesca Bergamo, Alessandra Anna Prete, Rossana Intini, Chiara Manai, Vincenzo Dadduzio, Alice Boscolo, Vittorina Zagonel & Sara Lonardi. (2017) Immunotherapy in Gastrointestinal Cancers. BioMed Research International 2017, pages 1-17.
Crossref
Tomohide Tsukahara, Yoshihiko Hirohashi, Takayuki Kanaseki, Munehide Nakatsugawa, Terufumi Kubo, Noriyuki Sato & Toshihiko Torigoe. (2016) Peptide vaccination therapy: Towards the next generation. Pathology International 66:10, pages 547-553.
Crossref
Vincent Sibaud, Nicolas Meyer, Laurence Lamant, Emmanuelle Vigarios, Julien Mazieres & Jean Pierre Delord. (2016) Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies. Current Opinion in Oncology 28:4, pages 254-263.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.